Results 281 to 284 of about 273,925 (284)

Totality of evidence refutes neoplasm risk with fezolinetant – Authors' reply

Lancet, The
Jonathan Douxfils, Charlotte Beaudart
exaly  

A myelodysplastic neoplasm with del(5q) treated with luspatercept uncovers unexplored mechanisms of action for the drug

British Journal of Haematology
Christina-Nefeli Kontandreopoulou, Dimitra Vlachopoulou, Christos Stafylidis   +2 more
exaly  

Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene

Leukemia and Lymphoma
Lei Xu, Chunji Gao
exaly  

Studies on drug resistance. V. Combination chemotherapy with cytosine arabinoside (NSC-63878) plus 6-thioguanine (NSC-752) in cytosine arabinoside-sensitive and -resistant P815 mouse neoplasms.

Cancer chemotherapy reports, 1974
openaire   +1 more source